Finally, although a statistically significant relationship between EPO therapy and a reduction in the incidence of 90-day recurrent stroke was noted in the current investigation, this study did not give cutoff and define positive and negative predictive values as well as provide sensitivities and specificities of EPO on clinical outcome because this study was not actually designed to perform a prognostic study. Here, EPO is linked to stroke disorder.